Author

Szymon Drygała

EFFECTIVENESS AND SAFETY OUTCOMES AFTER LONG-TERM (54 WEEKS) VEDOLIZUMAB THERAPY FOR CROHN'S DISEASE: A PROSPECTIVE, REAL-WORLD OBSERVATIONAL STUDY INCLUDING PATIENT-REPORTED OUTCOMES (POLONEZ II)
EFFECTIVENESS AND SAFETY OUTCOMES AFTER LONG-TERM (54 WEEKS) VEDOLIZUMAB THERAPY FOR CROHN'S DISEASE: A PROSPECTIVE, REAL-WORLD OBSERVATIONAL STUDY INCLUDING PATIENT-REPORTED OUTCOMES (POLONEZ II)

Szymon Drygała  et al.

Item 1 - 1 / 1
1